全文获取类型
收费全文 | 11561篇 |
免费 | 1117篇 |
国内免费 | 1779篇 |
出版年
2024年 | 29篇 |
2023年 | 180篇 |
2022年 | 342篇 |
2021年 | 581篇 |
2020年 | 447篇 |
2019年 | 536篇 |
2018年 | 529篇 |
2017年 | 414篇 |
2016年 | 518篇 |
2015年 | 739篇 |
2014年 | 948篇 |
2013年 | 957篇 |
2012年 | 1148篇 |
2011年 | 1043篇 |
2010年 | 657篇 |
2009年 | 610篇 |
2008年 | 698篇 |
2007年 | 598篇 |
2006年 | 601篇 |
2005年 | 437篇 |
2004年 | 381篇 |
2003年 | 326篇 |
2002年 | 249篇 |
2001年 | 133篇 |
2000年 | 126篇 |
1999年 | 95篇 |
1998年 | 106篇 |
1997年 | 70篇 |
1996年 | 68篇 |
1995年 | 58篇 |
1994年 | 58篇 |
1993年 | 40篇 |
1992年 | 62篇 |
1991年 | 46篇 |
1990年 | 57篇 |
1989年 | 46篇 |
1988年 | 36篇 |
1987年 | 30篇 |
1986年 | 29篇 |
1985年 | 33篇 |
1984年 | 46篇 |
1983年 | 30篇 |
1982年 | 34篇 |
1981年 | 42篇 |
1980年 | 24篇 |
1979年 | 24篇 |
1978年 | 20篇 |
1977年 | 23篇 |
1975年 | 23篇 |
1973年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
181.
Bo‐fang Zhang Hong Jiang Jing Chen Qi Hu Shuo Yang Xiao‐pei Liu Gen Liu 《Journal of cellular and molecular medicine》2020,24(1):1099-1115
Myocardial infarction (MI) remains the leading cause of morbidity and mortality worldwide, and novel therapeutic targets still need to be investigated to alleviate myocardial injury and the ensuing maladaptive cardiac remodelling. Accumulating studies have indicated that lncRNA H19 might exert a crucial regulatory effect on cardiovascular disease. In this study, we aimed to explore the biological function and molecular mechanism of H19 in MI. To investigate the biological functions of H19, miRNA‐22‐3p and KDM3A, gain‐ and loss‐of‐function experiments were performed. In addition, bioinformatics analysis, dual‐luciferase reporter assays, RNA immunoprecipitation (RIP) assays, RNA pull‐down assays, quantitative RT‐PCR and Western blot analyses as well as rescue experiments were conducted to reveal an underlying competitive endogenous RNA (ceRNA) mechanism. We found that H19 was significantly down‐regulated after MI. Functionally, enforced H19 expression dramatically reduced infarct size, improved cardiac performance and alleviated cardiac fibrosis by mitigating myocardial apoptosis and decreasing inflammation. However, H19 knockdown resulted in the opposite effects. Bioinformatics analysis and dual‐luciferase assays revealed that, mechanistically, miR‐22‐3p was a direct target of H19, which was also confirmed by RIP and RNA pull‐down assays in primary cardiomyocytes. In addition, bioinformatics analysis and dual‐luciferase reporter assays also demonstrated that miRNA‐22‐3p directly targeted the KDM3A gene. Moreover, subsequent rescue experiments further verified that H19 regulated the expression of KDM3A to ameliorate MI‐induced myocardial injury in a miR‐22‐3p‐dependent manner. The present study revealed the critical role of the lncRNAH19/miR‐22‐3p/KDM3A pathway in MI. These findings suggest that H19 may act as a potential biomarker and therapeutic target for MI. 相似文献
182.
The fruit of Crataegus dahurica Koehne was used to treat the disease of infantile indigestion and dyspepsia as an ethnic medicine and food. As a continuous work on finding the active constituents from the edible herbs, four new biphenyl derivatives ( 1 – 4 ), together with two known compounds ( 5 and 6 ), were obtained from the petroleum ether fraction of the fruits of C. dahurica. Their structures were determined by the extensive 1D and 2D NMR spectra and HR‐MS spectrometry. Furthermore, the anti‐inflammatory activities of all the isolated compounds were investigated, in which compound 4 showed moderately inhibitory effects on NO production in RAW264.7 cells without inducing cytotoxicity. 相似文献
183.
Geon‐Hyoung An John Hong Sangyeon Pak Yuljae Cho Sanghyo Lee Bo Hou SeungNam Cha 《Liver Transplantation》2020,10(3)
Recent supercapacitors show a high power density with long‐term cycle life time in energy‐powering applications. A supercapacitor based on a single metal electrode accompanying multivalent cations, multiple charging/discharging kinetics, and high electrical conductivity is a promising energy‐storing system that replaces conventionally used oxide and sulfide materials. Here, a hierarchically nanostructured 2D‐Zn metal electrode‐ion supercapacitor (ZIC) is reported which significantly enhances the ion diffusion ability and overall energy storage performance. Those nanostructures can also be successfully plated on various flat‐type and fiber‐type current collectors by a controlled electroplating method. The ZIC exhibits excellent pseudocapacitive performance with a high energy density of 208 W h kg?1 and a power density from 500 W kg?1, which are significantly higher than those of previously reported supercapacitors with oxide and sulfide materials. Furthermore, the fiber‐type ZIC also shows high energy‐storing performance, outstanding mechanical flexibility, and waterproof characteristics, without any significant capacitance degradation during bending tests. These results highlight the promising possibility of nanostructured 2D Zn metal electrodes with the controlled electroplating method for future energy storage applications. 相似文献
184.
185.
Yunzhen Wu Shuyan Cao Jungang Hou Zhuwei Li Bo Zhang Panlong Zhai Yanting Zhang Licheng Sun 《Liver Transplantation》2020,10(29)
Converting CO2 to valuable carbonaceous fuels and chemicals via electrochemical CO2 reduction by using renewable energy sources is considered to be a scalable strategy with substantial environmental and economic benefits. One of the challenges in this field is to develop nanocatalysts with superior electrocatalytic activity and selectivity for targeted products. Nonmetal species modification of nanocatalysts is of great significance for the construction of distinctive active sites to overcome the kinetic limitations of CO2 reduction. These types of modification enable the efficient control of the selectivity and significantly decrease the reaction overpotential. Herein, a comprehensive review of the recent progress of nonmetal species modification of nanocatalysts for electrochemical CO2 reduction is presented. After discussing some fundamental parameters and the basic principles of CO2 reduction, including possible reaction pathways in light of theoretical modeling and experiments, the identification of active sites and elucidation of reaction mechanisms are emphasized for unraveling the role of nonmetal species modification, such as heteroatom incorporation, organic molecule decoration, electrolyte engineering, and single‐atom engineering. In the final section, future challenges and constructive perspectives are provided, facilitating the accelerated advancement of mechanism research and practical applications of green carbon cycling. 相似文献
186.
目的:汉黄芩素是中药黄芩中的一种黄酮,具有体内外抗癌活性。然而,汉黄芩素对人胃癌细胞的作用尚不十分清楚。本研究拟探讨汉黄芩素对人胃癌细胞MGC-803侵袭转移能力的影响及其对上皮间质转化(Epithelial to Mesenchymal Transition,EMT)的作用机制。方法:采用MTT法测定汉黄芩素对人胃癌细胞MGC-803增殖能力的影响,通过划痕实验、Transwell试验检测汉黄芩素对人胃癌细胞MGC-803迁移、侵袭能力的影响。通过免疫印迹法和免疫荧光法分析汉黄芩素对EMT的影响。结果:20μM以上浓度的汉黄芩素能抑制人胃癌细胞MGC-803的增殖,不同浓度的汉黄芩素能抑制人胃癌细胞MGC-803的迁移和侵袭,且呈浓度依赖性。此外,汉黄芩素能抑制间质标记蛋白波形蛋白(Vimentin)和锌指蛋白E-盒结合同源异形盒-1(ZEB1)的表达,促进上皮标记蛋白E-钙黏蛋白(E-cadherin)的表达。结论:汉黄芩素能抑制胃癌细胞的侵袭和迁移,这一作用可能与其抑制EMT的发生有关。 相似文献
187.
188.
目的:比较伤椎置钉联合短节段内固定与单纯短节段固定治疗胸腰椎爆裂性骨折的临床疗效、固定效果及其对患者炎症反应和脊髓损伤的影响。方法:选取2014年3月到2016年12月期间我院收治的胸腰椎爆裂性骨折患者94例,根据手术方法的不同将患者分为伤椎置钉组(40例)和短节段内固定组(44例)。短节段内固定组患者采用单纯后路短节段椎弓根螺钉内固定进行治疗,伤椎置钉组采用伤椎置钉联合后路短节段椎弓根螺钉内固定进行治疗。比较两组患者的手术时间、术中出血量、住院时间、伤椎前沿高度比、Cobb’s角、伤椎椎体楔形变角、视觉模拟评分(VAS)和Oswestry功能障碍指数(ODI),炎性因子指标、脊髓损伤指标及术后并发症。结果:伤椎置钉组的手术时间长于短节段内固定组(P<0.05),术后6个月、术后12个月伤椎置钉组的伤椎前沿高度比明显高于短节段内固定组,Cobb’s角、伤椎椎体楔形变角明显低于短节段内固定组(P<0.05),术前、术后1周、术后6个月、术后12个月两组患者的VAS评分和ODI比较差异无统计学意义(P>0.05),术后3 d两组患者血清中IL-1β、IL-6、IL-8、TNF-α和pNF-H、NSE、S100β、GFAP水平比较差异均无统计学意义(P>0.05)。随访期间两组患者均未出现严重并发症。结论:伤椎置钉联合后路短节段椎弓根螺钉内固定可有效改善胸腰椎爆裂性骨折患者的椎体高度、Cobb’s角和伤椎椎体楔形变角,并且不会增加脊髓损伤和机体的炎症反应。 相似文献
189.
目的:探讨颅内动脉瘤夹闭术、血管内栓塞术治疗颅内动脉瘤的疗效及安全性。方法:回顾性分析2016年9月-2019年1月接受手术治疗的76例颅内动脉瘤患者的临床资料,根据手术方式的不同分为接受颅内动脉瘤夹闭术治疗的A组40例和接受血管内栓塞术治疗的B组36例。对比两组患者的动脉瘤完全闭合率、住院费用及血清炎性因子[C反应蛋白(CRP)、白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]、脑氧饱和度水平及日常生活能力量表(ADL)评分值,记录并发症发生情况。结果:两组患者的动脉瘤完全闭合率比较差异无统计学意义(x~2=0.515,P=0.473)。A组患者的住院费用低于B组患者(t=17.732,P=0.000);A组患者术后血清中CRP、IL-1β、IL-6、TNF-α的水平高于B组(t=10.580、12.904、9.355、19.176,P均=0.000);A组患者术后脑氧饱和度水平低于B组(t=2.113,P=0.019),两组ADL评分值的差异无统计学意义(t=1.211,P=0.115);A组术中再破裂、脑血管痉挛发生率高于B组患者(x~2=4.817、5.383,P=0.028、0.020)。结论:颅内动脉瘤夹闭术应用于颅内动脉瘤患者,动脉瘤完全闭合率与血管内栓塞术无明显差异,住院费用更低,但对目标血管的刺激较大,可能存在术中再破裂、脑血管痉挛等风险。 相似文献
190.
目的:评估解毒颗粒联合阿帕替尼治疗中晚期肝癌患者的疗效及其不良反应。方法:对2018年12月至2019年6月收治于海军军医大学第一附属医院口服解毒颗粒联合阿帕替尼的27例肝癌患者的临床资料进行回顾性研究。无法切除或复发的中晚期肝癌患者被纳入研究,给予解毒颗粒联合阿帕替尼治疗直至疾病进展或不可耐受其毒副反应,随访观察治疗效果、生存期、炎症因子指标及不良反应。结果:治疗后完全缓解(CR)4例(14.81%),部分缓解(PR)4例(14.81%),稳定(SD)8例(29.63%),进展(PD)11名患者(40.74%),疾病控制率(DCR)为59.26%(16/27),客观缓解率(ORR)为29.63%(8/27)。中位无进展生存期(PFS)为3.630个月,中位总生存期(OS)为13.667个月。常见的不良反应是高血压59.26%(16/27)、蛋白尿59.26%(16/27)、腹泻74.07%(20/27)以及手足综合征62.96%(17/27)。治疗后炎症因子指标中C反应蛋白、白介素2水平下降,存在统计学差异(P0.05)。结论:解毒颗粒联合阿帕替尼治疗中晚期肝癌安全、有效,可降低患者炎症反应,不良反应可耐受。 相似文献